Cash Grants and Tax Credits Now Available for Certain Biotech/Biopharma R&D Expenses
Mondaq Business Briefing › United States Law Articles in English (2010)
Linked as:
Extract
Cash Grants and Tax Credits Now Available for Certain Biotech/Biopharma R&D Expenses
Biotech and biopharma companies now have an opportunity to recover up to 50% of their qualified investments in qualifying therapeutic discovery projects as a cash grant or tax credit. The Patient Protection and Affordable Care Act (the Act) signed into law o...
See the full content of this document
Sponsored links
